MedPath

Relationship Between Liver Cancer and Sarcopenia

Conditions
Sarcopenia
Liver Cancer
Registration Number
NCT05339919
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Brief Summary

By tracking the short-term and long-term results of patients after hepatectomy, the difference of short-term results between patients with sarcopenia and patients without sarcopenia was analyzed, and the correlation between sarcopenia and short-term and long-term results of patients after hepatectomy was explored, so as to improve people's awareness of sarcopenia and pay attention to its prevention and treatment.

Detailed Description

All implementation details are based on the newest EWGSOP definition. The investigators consecutively admitted patients the questionnaire and evaluated the assessment of muscle strength (grip strength test and chair stand test), muscle quantity (L3 plane total skeletal muscle area) and physical performance (gait test) following the F-A-C-S approach, to confirm patients with sarcopenia accurately. And by tracking the short-term and long-term outcomes of patients after hepatectomy, the differences were analyzed and the relationship between sarcopenia and liver cancer was explored.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • Patients with preoperative clinical diagnosis of liver cancer
  • No cancer other than liver cancer has been diagnosed
  • Age ≥18 years
Read More
Exclusion Criteria
  • Patients who could not complete the standard tests and questionnaires
  • Patients who did not accept liver resection after evaluation of treatment plan
  • Patients who had other concomitant preoperative causes of muscle weakness (injury, fracture, stroke, etc.)
  • Patients who missing CT data or CT scan did not reach the level of the third lumbar vertebra (L3)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Short-term postoperative results3 months

Postoperative complications;90 days readmission rate

Long-term results after operation10 years

Overall survival; Disease free survival

Secondary Outcome Measures
NameTimeMethod
Postoperative hospitalization time2 months

Time window from the day of operation to the day of discharge.

Hospitalization expenses2 months

All hospitalization expenses, including drug expenses, operation expenses, anesthesia expenses, nursing expenses and other expenses.

Trial Locations

Locations (1)

Gang Chen

🇨🇳

Wenzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath